• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Cost-effectiveness of mechanical thrombectomy for acute ischemic stroke: an Australian payer perspective.
CONCLUSIONS: Mechanical thrombectomy is a cost-effective treatment option for AIS, with clinical benefits translating to short and long-term cost benefits. This analysis supports rapid update of stroke care pathways to incorporate this therapy as a treatment option. PMID: 29741126 [PubMed - as supplied by publisher]
Source: Journal of Medical Economics - May 11, 2018 Category: Health Management Tags: J Med Econ Source Type: research

Estimating the public economic consequences of cardiovascular disease-attributable events and evolocumab treatment in Australia.
CONCLUSIONS: Applying a cross-sectorial government perspective budget impact assessment improves our understanding of fiscal changes attributed to ASCVD based on changes in premature mortality and work activity and how this influences lifetime tax contributions and public benefits. The main cost driver observed was associated with reduced ASCVD events that enabled people to remain productive and paying taxes. PMID: 33464137 [PubMed - as supplied by publisher]
Source: Journal of Medical Economics - January 20, 2021 Category: Health Management Tags: J Med Econ Source Type: research